Genetically engineered tumor-selective vaccinia virus (VV) has been demonstrated to be a highly effective oncolytic agent, but immune clearance may limit its therapeutic potential. As previously ...
Tremendous efforts are being made to develop potent gene delivery systems for gene therapy. Viral vectors derived from naturally occurring viruses, such as adenoviruses, adeno-associated viruses, ...